Table of Contents

A patent infringement analysis Rome rights-holders can rely on has to be built for the way Italy actually proves infringement — through a court-appointed technical expert, a pre-trial evidence seizure, and a specialised business division rather than a generalist bench. Rome is the seat of Italy’s patent administration and one of only three cities, with Milan and Turin, that anchor the country’s patent-litigation map. It is also the capital of Lazio, a region that is Italy’s largest pharmaceutical exporter and the headquarters of its aerospace and defence champion, Leonardo. Those industries write a distinctive infringement docket: formulation and process chemistry, analytical methods and SPCs on one side; avionics, space hardware and defence electronics on the other. PerspireIP builds the element-by-element claim charts and dated evidence-of-use that a Roman judge, a UPC panel and above all the CTU can adopt.
Where a patent infringement analysis Rome case is heard
Italy does not spread patent cases across every civil court. Infringement and validity actions are reserved to the sezioni specializzate in materia di impresa — the specialised business divisions widely known as the Tribunale delle Imprese — sitting in a limited set of courts. Rome, Milan and Turin are the three principal centres, and the Tribunale di Roma runs a dedicated IP and business division that serves central and southern Italy. Judges there hear intellectual-property disputes as their steady diet, so a case rewards a rigorous, limitation-by-limitation read of the claim over rhetoric.
Rome also carries a jurisdictional quirk that matters to international clients. When a defendant is foreign-domiciled, Italian law channels the case into a narrower group of specialised divisions, and where neither party is domiciled in Italy the Court of Rome takes jurisdiction. The first-hearing term is also extended — 150 days for a foreign defendant against 90 for a domestic one. For a cross-border dispute touching Italy, Rome is frequently not just an option but the default forum.
- Tribunale di Roma, specialised business division — hears patent infringement and validity actions for central and southern Italy, and takes jurisdiction where neither party is domiciled in Italy
- Sezioni specializzate in materia di impresa — the limited set of IP-competent courts, of which Rome, Milan and Turin are the principal centres
- Corte d’Appello di Roma — reviews first-instance patent judgments from the Roman division
- Extended first-hearing term — 150 days for foreign-domiciled defendants, reflecting Rome’s role in cross-border matters
The descrizione and the CTU: how Italy proves infringement
Two features make Italian patent proof unlike common-law discovery, and both shape the evidence file from day one. The first is the descrizione — a saisie-style pre-trial description order. Because Italy has no general discovery, a rights-holder can ask the court, often ex parte and within days, to send an officer and an independent expert into the alleged infringer’s premises to describe and document the accused product, its process and the related records before suit. A parallel sequestro (seizure) can secure samples and goods. The descrizione is how you capture the facts that a formulation, a manufacturing process or a piece of hardware would otherwise conceal.
The second feature is the CTU — the consulente tecnico d’ufficio, a court-appointed technical expert. Italian patent trials turn on a technical enquiry in which the CTU, assisted by each side’s party experts (consulenti tecnici di parte), delivers an official opinion on validity and infringement. Because the legal judges typically have no engineering or chemistry background, they lean heavily on the CTU’s report. Winning in Rome therefore means winning the CTU: the claim chart has to be one the expert can verify, adopt and defend in a written reply.
- Descrizione — a court-authorised description order, frequently granted ex parte, that documents the accused product and process before trial in the absence of discovery
- Sequestro — seizure of infringing samples, goods and evidence to preserve the record
- CTU (consulente tecnico d’ufficio) — the neutral court expert whose opinion on infringement and validity effectively decides the technical case
- Consulenti tecnici di parte — the party-appointed experts who argue each side’s reading into the CTU’s enquiry
This is why a patent infringement analysis Rome parties commission cannot stop at a tidy conclusion. It has to anticipate the descrizione’s haul and be written for a CTU who will test every mapped limitation against the seized product and the file.
Italy, the UPC and the Milan Central Division section
Italy is a full member of the Unified Patent Court (UPC), live since 1 June 2023, so for a European patent that has not been opted out a second, pan-European route runs alongside the national one. A UPC judgment reaches across every participating member state at once, which changes the strategic calculus for a patentee weighing a purely Italian action before the Tribunale di Roma against a continent-wide injunction.
Italy’s stake in the UPC is not only local divisions. On 26 June 2024 the UPC opened a third section of its Central Division in Milan, joining Paris and Munich. The Milan section handles cases in IPC class A — “human necessities”, which includes pharmaceuticals and medical devices — without supplementary protection certificates. That assignment sits squarely on Lazio’s pharmaceutical strength, so a Roman rights-holder may find its European action decided in Milan even as its national action stays in Rome. We keep Rome’s own forum central and scope the analysis to whichever track will decide the case.
- National route — the Tribunale di Roma specialised division for Italian and validated European patents not litigated at the UPC
- UPC route — infringement and revocation of non-opted-out European patents and unitary patents, with pan-European effect
- UPC Central Division, Milan section — opened 26 June 2024, hearing IPC class A “human necessities” cases without SPCs, directly relevant to Lazio pharma
Rome and Lazio industry: pharma, aerospace, defence and media
Rome’s patent docket is written by its regional economy, and Lazio’s is unusually concentrated. The region is Italy’s leading pharmaceutical-exporting region and one of Europe’s largest pharma manufacturing and export hubs, with a dense chemical-pharmaceutical belt running through the Latina and Frosinone provinces. Menarini runs biotech and manufacturing sites in the Rome area (Pomezia); Angelini is headquartered in Rome; and multinationals including MSD and Catalent operate large sites around Aprilia and Anagni. Pharma patents generate the hardest infringement questions: formulation, polymorph and process claims, analytical-method claims, and supplementary protection certificates that extend exclusivity.
The second pillar is aerospace and defence. Leonardo S.p.A., Italy’s aerospace, defence and security champion, is headquartered in Rome; Telespazio is Rome-based; Thales Alenia Space and Avio anchor a space cluster; and the Italian Space Agency (ASI) sits in the capital. These disputes turn on avionics, satellite and launch hardware, telemetry and defence electronics — matters proven by teardown, layout and firmware analysis and, where the descrizione allows, by inspection of the physical article itself.
- Pharma & life sciences — formulation, polymorph, process and analytical-method claims and SPCs, mapped from batch records, specifications and reverse-formulation chemistry captured by descrizione
- Aerospace & defence — avionics, space and launch hardware, telemetry and defence electronics, proven by teardown, layout extraction and firmware analysis
- Media & broadcast — the Rome hub of RAI and Cinecittร drives codec, streaming and content-delivery patents proven from behaviour, bitstreams and logs
- Cross-sector electronics — sensors, control systems and connectivity common to all three, where several portfolios read on one accused device
Building claim charts and evidence-of-use for a Roman forum
The specialised Roman judges and the UPC’s technically qualified panels expect a disciplined evidentiary file, and the CTU expects a chart it can independently verify. We start from claim construction — claims, specification and prosecution history — then map each limitation against the real accused product and process, literally and, where appropriate, under the doctrine of equivalents as applied in Italy.
- Element-by-element claim charts tying every limitation to a documented, dated piece of evidence a CTU can re-run
- Pharma evidence-of-use from reverse-formulation and process chemistry, analytical data, batch and regulatory records, with the SPC scope pinned down
- Aerospace and defence evidence-of-use from teardown, layout extraction, telemetry and firmware analysis of the accused hardware
- Non-infringement and design-around positions for an accused party, with claim construction anchored to the specification and file wrapper
- A coordinated invalidity file, because a nullity counterclaim runs alongside the infringement action in Rome and at the UPC
- Evidence packaged to survive a descrizione and to feed the CTU’s enquiry and the party experts’ replies
The deliverable is scoped to the forum. A national action before the Tribunale di Roma, an Italian descrizione, or a UPC infringement or revocation action each demands a slightly different package. What never changes is the core: a claim chart an independent CTU and a specialist judge can adopt, built on evidence rather than conclusions.
How PerspireIP scopes a Rome infringement-analysis engagement
Every engagement follows the same path. We fix the correct claim construction, map each element against the accused product, and assemble evidence-of-use in the form the technology demands — chemistry and regulatory records for pharma, teardown and firmware for aerospace and defence, behaviour and bitstreams for media. Then we build the file the Italian process actually uses: material a descrizione can secure and a CTU can verify.
- Claim construction and element-by-element charting against an Italian national patent, a validated European patent or a unitary patent
- Evidence-of-use assembly dated and documented for a descrizione, a Tribunale di Roma judge or a UPC panel
- Infringement and non-infringement positions built for either side, coordinated with any parallel nullity or revocation challenge
- Deliverables scoped to the track — a Roman complaint, a descrizione application, or a UPC statement of claim
We work alongside your Italian and international counsel as a specialist analysis partner, deliver to Tribunale di Roma and UPC deadlines, and keep every engagement confidential. Whether you are a pharma, aerospace, defence or media company enforcing a portfolio, an accused party clearing a path to market, or litigation counsel preparing a claim or a defence, we scale to fit — a single claim chart, a multi-patent matter, or ongoing portfolio support. Send us the patent number and the accused product, and we will scope the work within one business day.
IP Landscape & Resources in Rome
Key intellectual-property authorities and venues relevant to Rome:
- UIBM (Ufficio Italiano Brevetti e Marchi) — the Italian Patent and Trademark Office, part of the Ministry of Enterprises and Made in Italy (MIMIT) and headquartered in Rome, which grants Italian patents and registers Italian trademarks and designs
- Tribunale di Roma — the Court of Rome, whose specialised business division (sezione specializzata in materia di impresa) hears patent infringement and validity actions for central and southern Italy and takes jurisdiction where neither party is domiciled in Italy
- Unified Patent Court (UPC) — the pan-European court that hears infringement and revocation of non-opted-out European patents and unitary patents, with a section of its Central Division opened in Milan on 26 June 2024 for human-necessities cases
- European Patent Office (EPO) — the office that grants European patents which, once validated in Italy or granted unitary effect, are enforced before the Tribunale di Roma or the UPC
Request a Patent Infringement Analysis in Rome
Request a Patent Infringement Analysis in Rome
Get CTU-ready claim charts and dated evidence-of-use built for the specialised business division of the Tribunale di Roma, an Italian descrizione and the Unified Patent Court โ for pharma, aerospace, defence and media disputes across Rome and Lazio. Send us the patent number and the accused product, and we will scope the work within one business day.
Explore related PerspireIP services: Patent Infringement Analysis · Prior Art Litigation Search · Patent Invalidation.
Frequently Asked Questions
Which court hears a patent-infringement case in Rome?
Italy reserves patent infringement and validity actions to the specialised business divisions (sezioni specializzate in materia di impresa), and the Tribunale di Roma runs one that serves central and southern Italy. Rome is one of the three principal centres alongside Milan and Turin. Rome also carries a jurisdictional quirk that matters to international clients: where a defendant is foreign-domiciled the case is channelled into a narrower set of specialised divisions, and where neither party is domiciled in Italy the Court of Rome itself takes jurisdiction, with the first-hearing term extended to 150 days. For a non-opted-out European patent, the Unified Patent Court is an alternative forum with pan-European effect.
What is a descrizione and why does it matter for an infringement analysis?
Because Italy has no general discovery, a rights-holder relies on the descrizione, a saisie-style pre-trial description order. On application, often ex parte and within days, the court sends an officer and an independent expert into the alleged infringer’s premises to describe and document the accused product, its manufacturing process and related records before suit; a parallel sequestro can seize samples and goods. The descrizione is how you capture the facts a formulation, a process or a piece of hardware would otherwise hide. A useful infringement analysis is therefore written to anticipate what the descrizione will secure and to turn that material into mapped claim limitations.
What is the CTU and how does it decide the case?
The CTU is the consulente tecnico d’ufficio, a court-appointed technical expert. Italian patent trials turn on a technical enquiry in which the CTU, assisted by each side’s party experts (consulenti tecnici di parte), delivers an official opinion on validity and infringement. Because the legal judges usually have no engineering or chemistry background, they lean heavily on the CTU’s report, which effectively decides the technical case. That is why our claim charts are built to be verified, adopted and defended by a neutral expert rather than merely to persuade a lawyer: every mapped limitation is tied to evidence the CTU can independently re-run.
Is Italy in the UPC, and where would a Rome pharma case be decided?
Yes. Italy is a full member of the Unified Patent Court, live since 1 June 2023, so a non-opted-out European patent can be litigated with pan-European effect instead of, or alongside, a national action in Rome. Italy’s role is significant: on 26 June 2024 the UPC opened a third section of its Central Division in Milan, joining Paris and Munich, and that section handles IPC class A ‘human necessities’ cases (including pharmaceuticals and medical devices) without supplementary protection certificates. Given Lazio’s pharmaceutical strength, a Roman rights-holder’s European action may well be decided in Milan even while its national action stays before the Tribunale di Roma.